chr11-31594882-A-C

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_019040.5(ELP4):​c.494A>C​(p.Gln165Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000071 in 1,407,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

ELP4
NM_019040.5 missense

Scores

10
5
4

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 7.91

Publications

0 publications found
Variant links:
Genes affected
ELP4 (HGNC:1171): (elongator acetyltransferase complex subunit 4) This gene encodes a component of the six subunit elongator complex, a histone acetyltransferase complex that associates directly with RNA polymerase II during transcriptional elongation. The human gene can partially complement sensitivity phenotypes of yeast ELP4 deletion mutants. This gene has also been associated with Rolandic epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
ELP4 Gene-Disease associations (from GenCC):
  • aniridia 2
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Genomics England PanelApp
  • aniridia 1
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.883

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELP4NM_019040.5 linkc.494A>C p.Gln165Pro missense_variant Exon 4 of 10 ENST00000640961.2 NP_061913.3 Q96EB1-1
ELP4NM_001288726.2 linkc.494A>C p.Gln165Pro missense_variant Exon 4 of 12 NP_001275655.1 Q96EB1G5E9D4
ELP4NM_001288725.2 linkc.494A>C p.Gln165Pro missense_variant Exon 4 of 11 NP_001275654.1 Q96EB1-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELP4ENST00000640961.2 linkc.494A>C p.Gln165Pro missense_variant Exon 4 of 10 1 NM_019040.5 ENSP00000492152.1 Q96EB1-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.10e-7
AC:
1
AN:
1407920
Hom.:
0
Cov.:
30
AF XY:
0.00000143
AC XY:
1
AN XY:
698832
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30128
American (AMR)
AF:
0.0000317
AC:
1
AN:
31500
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24848
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36836
South Asian (SAS)
AF:
0.00
AC:
0
AN:
73798
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53026
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5650
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1093966
Other (OTH)
AF:
0.00
AC:
0
AN:
58168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 18, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.494A>C (p.Q165P) alteration is located in exon 4 (coding exon 4) of the ELP4 gene. This alteration results from a A to C substitution at nucleotide position 494, causing the glutamine (Q) at amino acid position 165 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Dec 14, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 165 of the ELP4 protein (p.Gln165Pro). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ELP4-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.63
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.17
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Benign
0.19
T;.;.;.;.;.;.;.;.;.;.;.
Eigen
Pathogenic
0.81
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.97
D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.043
D
MetaRNN
Pathogenic
0.88
D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.31
T
MutationAssessor
Pathogenic
3.4
M;.;M;.;.;.;.;.;.;.;.;.
PhyloP100
7.9
PrimateAI
Uncertain
0.49
T
PROVEAN
Pathogenic
-5.2
.;.;D;.;D;.;.;.;.;.;.;D
REVEL
Uncertain
0.60
Sift
Uncertain
0.0030
.;.;D;.;D;.;.;.;.;.;.;D
Sift4G
Uncertain
0.0050
.;.;D;.;D;.;.;.;.;.;.;D
Polyphen
1.0
D;.;.;.;.;.;.;.;.;.;.;D
Vest4
0.76, 0.78, 0.80
MutPred
0.72
Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);Loss of MoRF binding (P = 0.0542);
MVP
0.78
MPC
0.37
ClinPred
1.0
D
GERP RS
5.1
Varity_R
0.86
gMVP
0.80
Mutation Taster
=49/51
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1957646200; hg19: chr11-31616429; API